BioSpace News Archive

Business

Axsome Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Update

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today reported financial results for the third quarter ended September 30, 2022.

November 7, 2022
·
15 min read
Business

Amicus Therapeutics Announces Third Quarter 2022 Financial Results and Corporate Updates

Amicus Therapeutics today announced financial results for the quarter ended September 30, 2022.

November 7, 2022
·
20 min read
Deals

Bio-Path Holdings, Inc. Announces $2.0 Million Registered Direct Offering and Concurrent Private Placement

Bio-Path Holdings, Inc., today announced that it has entered into a definitive agreement with certain institutional investors for the issuance and sale of 800,000 shares of its common stock (or common stock equivalents) for a price of $2.50 per share.

November 7, 2022
·
5 min read
Business

Nanoscope Therapeutics Expands Clinical and CMC Leadership Team with Gene Therapy Pharma Experience

Nanoscope Therapeutics, Inc. today announced that the Company has expanded its clinical and Chemistry, Manufacturing and Controls (CMC) team with the appointments of Jean Chang, as VP of Clinical Operations and Victor Adeniyi s Senior Director of CMC.

November 7, 2022
·
2 min read
Chemomab Presents Preclinical Data at AASLD The Liver Meeting® 2022 Highlighting Key Role of CCL24 in Pathophysiology of Primary Sclerosing Cholangitis

Chemomab Therapeutics, Ltd. today announced a poster presentation at The Liver Meeting® 2022, hosted by the American Association for the Study of Liver Diseases (AASLD), being held in Washington, D.C. November 4-8, 2022.

November 7, 2022
·
6 min read
CollPlant Expands rhCollagen-Based Bioink Platform with Launch of Collink.3D™ 90

CollPlant today announced the Company is launching Collink.3D™ 90, a recombinant human collagen (rhCollagen)-based bioink for use in a variety of 3D bioprinting applications.

November 7, 2022
·
6 min read
Pharm Country

Synchrony Airway Clearance System Prototype Helps Save Patient’s Life

Synchrony Medical ‘s LibAirty, helped save the life of a 38-year-old patient who traveled from Israel to the U.S.

November 7, 2022
·
3 min read
Bausch + Lomb Announces Participation at the 5th Annual Evercore ISI HealthCONx Conference

Bausch + Lomb Corporation, today announced that Joseph C. Papa , chief executive officer, and Sam Eldessouky , executive vice president and chief financial officer are scheduled to participate at the 5th Annual Evercore ISI HealthCONx Conference on Nov. 30, 2022, at 9:40 a.m. ET.

November 7, 2022
·
1 min read
Asep Inc. is Granted Patent Approval for its Sepsis Diagnostic Technology in 13 European Countries and Australia

Asep Medical Holdings Inc. is very pleased to announce that the Company’s sepsis diagnostic technology, called Sepset ER TM, has received successful patent approval in 13 European countries as well as in Australia.

November 7, 2022
·
5 min read
Drug Development

Ionis presents positive Phase 2 data in patients with IgA Nephropathy at American Society of Nephrology’s Kidney Week 2022

Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today presented positive results from a Phase 2 clinical study of IONIS-FB-L Rx in patients with immunoglobulin A nephropathy (IgAN).

November 7, 2022
·
4 min read